About 280,000 to 300,000 people in the United States are estimated to be living with Chagas disease, mostly immigrants from Latin America and a smaller cohort of US-born cases. The CDC added Chagas to its list of Neglected Parasitic Infections in 2014 to push for better surveillance and screening. The chronic phase, which develops decades after infection, causes heart failure and arrhythmias that kill roughly 12,000 people across the Americas annually.
The disease is endemic across 21 Latin American countries from northern Mexico to Argentina. Triatomine bugs (also called kissing bugs) live in the cracks of mud-walled rural houses and emerge at night to feed on sleeping humans. This post fits inside the outbreak-aware travel guide and complements disease risks by region and One Health framework.
Key Takeaways
- Chagas disease is caused by Trypanosoma cruzi parasite, transmitted by triatomine "kissing bugs" across the Americas.
- About 6 million people are infected globally; 280,000 to 300,000 are in the US.
- Most cases acquired in the US come from contaminated food, blood transfusion, or vertical transmission from mother to child, with rare bite-route transmission documented.
- The acute phase is usually mild or asymptomatic; the chronic phase 10 to 30 years later causes cardiomyopathy in 20 to 30 percent.
- Two licensed antiparasitic treatments (benznidazole and nifurtimox) are most effective in acute and early chronic infection.
- US blood and organ donations have been screened since 2007; transfusion-acquired Chagas is now rare.
What is Chagas disease?
Chagas disease, also called American trypanosomiasis, is caused by the protozoan parasite Trypanosoma cruzi. The parasite cycles between mammals (raccoons, opossums, dogs, armadillos, humans) and triatomine bugs. The bug feeds on blood, defecates near the bite, and the parasite enters when the host scratches infected feces into the wound.
The disease has two clinical phases. The acute phase begins 1 to 2 weeks after exposure and lasts about 2 months. The chronic phase follows; in most patients it is asymptomatic for life, but 20 to 30 percent eventually develop heart disease, GI complications, or both.
Carlos Chagas described the parasite, vector, and disease in 1909, a complete discovery cycle rarely attributed to a single researcher in tropical medicine. The disease bears his name across both English and Spanish public health literature.
How does transmission happen?
The vectorial route through triatomine bugs is dominant in rural Latin America but rare in the US.
| Route | Frequency in endemic areas | Frequency in US |
|---|---|---|
| Triatomine vector | Most common | Rare but documented |
| Mother to child | 5 percent of infected pregnancies | Significant |
| Blood transfusion | Historically common, now screened | Very rare since 2007 screening |
| Organ transplant | Documented | Rare; donors screened |
| Contaminated food/beverage | Increasing (acai, fruit juices in Brazil) | Rare |
| Laboratory accident | Occasional | Very rare |
Triatomine bugs live in cracks and crevices of poor-quality housing: mud walls, palm-thatched roofs, behind pictures or beds. They emerge at night, feed for 20 minutes or more, and defecate during or after feeding. The parasite must enter through the bite, an abrasion, eye, or mucous membrane to cause infection.
In the US, triatomine bugs are present in the southern half of the country, but the species are less efficient at transmission and most encounters do not result in infection. US-acquired cases are documented in Texas, Louisiana, and California in particular.
What does the acute phase look like?
Acute Chagas appears 1 to 2 weeks after exposure. Symptoms are nonspecific:
- Fever, malaise, swollen lymph nodes
- Hepatosplenomegaly
- Romaña's sign: unilateral painless eyelid swelling when the parasite enters through the eye
- Chagoma: indurated skin lesion at the bite site
- Rarely: myocarditis or meningoencephalitis (more common in children and immunocompromised)
Most acute cases resolve spontaneously within 4 to 8 weeks. The parasite then persists in tissues for decades, particularly cardiac and gastrointestinal smooth muscle.
Acute symptoms are mild enough that most infections are never diagnosed. Patients present years or decades later when chronic complications develop, by which point treatment efficacy has declined.
What is chronic Chagas disease?
After the acute phase, about 60 to 70 percent of infected people remain in an indeterminate form: T. cruzi antibodies positive, no clinical disease, normal cardiac and GI function. The other 30 to 40 percent eventually develop one of three chronic patterns:
Chagas cardiomyopathy (20 to 30 percent of chronic cases):
- Dilated cardiomyopathy with reduced ejection fraction
- Conduction abnormalities, particularly right bundle branch block
- Ventricular arrhythmias including sudden cardiac death
- Apical aneurysm and thrombus formation
Digestive Chagas (less common, more in Brazil and Southern Cone):
- Megaesophagus: progressive difficulty swallowing
- Megacolon: chronic constipation, sometimes requiring surgical resection
Mixed cardiac and digestive forms.
Chagas cardiomyopathy is one of the leading causes of heart failure in much of Latin America. Sudden cardiac death is the most common mode of death.
How is it diagnosed?
The diagnostic approach differs by phase.
Acute phase:
- Direct visualization of trypomastigotes on blood smear
- PCR on blood, becoming more accessible
- Serology may be negative early; repeat at 30 to 60 days
Chronic phase:
- Two different serologic tests required for confirmation (CDC standard)
- IFA, ELISA, and chemiluminescent immunoassays all commercially available
- Hemoculture and PCR have lower sensitivity in chronic phase
- Cardiac and GI evaluation if seropositive
Serologic screening is now standard for US blood donations and organ donors. Pregnant women born in endemic countries should be screened, and infants of seropositive mothers should be tested at birth and at 9 months. The PCR vs antigen vs serology guide covers the broader testing logic.
What treatments exist?
Two antiparasitic drugs are licensed: benznidazole and nifurtimox. Both achieve high cure rates in acute disease (60 to 80 percent), moderate cure rates in early chronic disease in children (30 to 60 percent), and limited efficacy in established chronic disease.
Benznidazole gained full FDA approval in 2017 for children aged 2 to 12; broader US use is now possible. Both drugs have significant side effects: rash, peripheral neuropathy, GI upset, leukopenia. Treatment runs 60 to 90 days under monitoring.
Chronic Chagas cardiomyopathy management mirrors heart failure care: ACE inhibitors or ARBs, beta blockers, diuretics, antiarrhythmics. Implantable defibrillators and pacemakers are common. Heart transplantation is performed for end-stage disease with good outcomes; transplant teams in Texas, Florida, and California have substantial Chagas experience.
How do travelers reduce risk?
For most travelers, risk is very low. Standard tourist accommodation in cities does not harbor triatomine bugs. Risk rises substantially in rural Latin America with overnight stays in adobe, mud-walled, or palm-thatched housing in endemic areas.
Practical precautions:
- Inspect bedrooms for cracks, crevices, and signs of insect activity
- Sleep under permethrin-treated bed nets if accommodation quality is uncertain
- Use insect repellent if exposure is unavoidable
- Avoid sleeping in close contact with dogs, which can harbor triatomine populations
- Avoid unpasteurized acai juice and other fresh fruit juices in Brazil, which have caused outbreak clusters
The outbreak-aware travel guide covers broader pre-departure planning. Pre-travel consultation with a tropical medicine specialist is appropriate for long-term rural stays in endemic areas.
FAQ
Are kissing bugs in the US really transmitting Chagas?
Yes, but rarely. Triatomine species in the US (Triatoma sanguisuga, T. gerstaeckeri, T. rubida) carry T. cruzi at variable rates depending on region. They are less efficient transmitters than the South American species because they defecate later relative to feeding. Confirmed US autochthonous cases number in dozens to low hundreds, not thousands.
Can dogs carry Chagas?
Yes. Dogs in the southern US and across Latin America can be infected and serve as reservoirs. Chagas cardiomyopathy in working dogs has been studied extensively in Texas. Veterinary screening is available; dogs cannot directly transmit to humans, but infected dogs may indicate local triatomine activity.
Why is Chagas called a neglected disease?
The 6 million infected, 12,000 annual deaths, and economic burden across Latin America have historically received funding and pharmaceutical research disproportionately less than comparable disease burdens elsewhere. CDC's Neglected Parasitic Infections initiative, WHO's NTD program, and DNDi (Drugs for Neglected Diseases initiative) work to close those gaps. The label reflects historical underinvestment rather than lack of impact.
Should immigrants from Latin America get screened?
CDC recommends screening for adults born in endemic Latin American countries, especially those with rural childhood exposure or cardiac symptoms. Routine screening of pregnant women from endemic regions is also advised. Identifying chronic infection allows monitoring for cardiac complications and antiparasitic treatment in selected cases.
Will the disease ever be eliminated?
Vector control programs in the Southern Cone (Argentina, Uruguay, Brazil, Chile, Paraguay) have substantially reduced transmission. Several countries have been certified as having interrupted vectorial transmission by Triatoma infestans. Elimination from the Americas as a whole is challenging because of sylvatic cycles in wildlife reservoirs, but WHO targets continued reduction in incidence and mortality through 2030.